Ron G. Rosenfeld MD, americký pediatr, endokrinolog.
Rosenfeld, Ron G.
Rosenfeld, R. G.
Rosenfeld, Ron G., 1946-
VIAF ID: 49395660 (Personal)
Permalink: http://viaf.org/viaf/49395660
Preferred Forms
- 100 0 _ ‡a Ron G. Rosenfeld ‡c MD, americký pediatr, endokrinolog.
- 200 _ | ‡a Rosenfeld ‡b Ron G.
-
- 100 1 _ ‡a Rosenfeld, R. G.
-
- 100 1 0 ‡a Rosenfeld, Ron G.
-
- 100 1 _ ‡a Rosenfeld, Ron G.
-
-
- 100 1 0 ‡a Rosenfeld, Ron G.
- 100 1 _ ‡a Rosenfeld, Ron G.
-
-
-
4xx's: Alternate Name Forms (7)
Works
Title | Sources |
---|---|
12th International Symposium on Growth and Growth Disorders : proceedings of a meeting held in Geneva, Switzerland, 25-26 October 1991 | |
Growth abnormalities, 1987: | |
The IGF system, c1999: | |
The IGF system : molecular biology, physiology, and clinical applications | |
The insulin-like growth factors and their regulatory proteins : proceedings of the Third International Symposium on Insulin-Like Growth Factors, Sydney, 6-10 February 1994 | |
Management of short stature in children with normal GH levels | |
The mouse intraovarian insulin-like growth factor I system: departures from the rat paradigm | |
The ovarian expression of the antigonadotropic insulin-like growth factor binding protein-2 is theca-interstitial cell-selective: evidence for hormonal regulation | |
Prospective clinical trial of human growth hormone in short children without growth hormone deficiency | |
Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma | |
Proteolysis of IGFBP-3 may be a common regulatory mechanism of IGF action in vivo | |
Purification of the insulin-like growth factor II (IGF-II) receptor from an IGF-II-producing cell line, and generation of an antibody which both immunoprecipitates and blocks the type 2 IGF receptor | |
Recent advances in growth research : nutritional, molecular and endocrine perspectives | |
Recombinant DNA-derived methionyl human growth hormone is similar in membrane binding properties to human pituitary growth hormone | |
Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin | |
Reproducibility in patterns of IGF generation with special reference to idiopathic short stature | |
Results from the first 2 years of a clinical trial with recombinant DNA-derived human growth hormone (somatrem) in Turner's syndrome | |
The roles of insulin sensitivity, insulin-like growth factor I (IGF-I), and IGF-binding protein-1 and -3 in the hyperandrogenism of African-American and Caribbean Hispanic girls with premature adrenarche | |
Safety of recombinant deoxyribonucleic acid-derived growth hormone: The National Cooperative Growth Study experience | |
Safety Outcomes During Pediatric GH Therapy: Final Results From the Prospective GeNeSIS Observational Program | |
Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes | |
Sensitivity to growth hormone-the perspective. Round table discussion. | |
Serum free thyroxine values in term, premature, and sick infants | |
Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. | |
Serum glucocorticoids have persistent and controlling effects on insulinlike growth factor I action under serum-free assay conditions in cultured human fibroblasts | |
Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. | |
Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum | |
Severe growth deficiency is associated with STAT5b mutations that disrupt protein folding and activity | |
Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b. | |
Severe short stature caused by novel compound heterozygous mutations of the insulin-like growth factor 1 receptor (IGF1R) | |
Sex chromosome fragment in a phenotypically normal female. Significance of occult Y-related material | |
Sexual and somatic determinants of the human Y chromosome: studies in a 46,XYp- phenotypic female | |
Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone | |
Simultaneous inhibition of insulin and somatomedin-C binding to cultured IM-9 lymphocytes by naturally occurring antireceptor antibodies | |
Somatic and intellectual development in a patient with 47,XX,psu dic(X)(p11.2) chromosome constitution | |
Somatomedin-C in accelerated growth of children with precocious puberty | |
Somatomedin C/insulin-like growth factor I binding and action in human fibroblasts aged in culture: impaired synergism with dexamethasone | |
Somatomedin peptide distribution and somatomedin-binding protein content in cord plasma: comparison to normal and hypopituitary plasma | |
Somatomedins in pregnancy: a cross-sectional study of insulin-like growth factors I and II and somatomedin peptide content in normal human pregnancies | |
STAT5b deficiency: an unsuspected cause of growth failure, immunodeficiency, and severe pulmonary disease | |
STAT5b deficiency: lessons from STAT5b gene mutations | |
STAT5B mutations in heterozygous state have negative impact on height: another clue in human stature heritability | |
Structural and immunological comparison of insulin-like growth factor binding proteins of cerebrospinal and amniotic fluids | |
Structural characterization and immunohistochemical localization of receptors for insulin-like growth factor II in the rat pituitary gland | |
Subcutaneous versus intramuscular growth hormone therapy: growth and acute somatomedin response | |
Total absence of functional acid labile subunit, resulting in severe insulin-like growth factor deficiency and moderate growth failure. | |
Toward a molecular basis for idiopathic short stature | |
Transcriptional regulation of insulin-like growth factor-I by interferon-gamma requires STAT-5b | |
Transfection of the human IGFBP-3 gene into Balb/c fibroblasts: a model for the cellular functions of IGFBPs | |
Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. | |
The transition from adolescence to adult life: physiology of the 'transition' phase and its evolutionary basis | |
Transitioning patients with childhood-onset growth hormone deficiency to treatment in adulthood. | |
Transplantation of insulin-like growth factor-II-secreting tumors into nude rodents | |
Trastornos del crecimiento | |
Treatment of short stature and delayed adolescence | |
Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency | |
Triiodothyronine regulates insulin-like growth factor-I binding to cultured rat pituitary cells | |
Triple A syndrome in a patient with genetic growth hormone insensitivity: phenotypic effects of two genetic disorders. | |
Turner syndrome | |
Two decades of experience in growth, c1993: | |
Up-regulation of IGF-I receptors on IM-9 cells by IGF-II peptides. | |
Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults | |
The utility of the IGF-I generation test in children with chronic kidney disease | |
Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children |